CEO Moves this week include:
|AccuWeather||Angion Biomedica Corp.||Immunocore Limited|
|Allena Pharmaceuticals, Inc.||Owens Corning||Retrophin, Inc.|
|RetailMeNot, Inc.||Aver Healthcare||Tizona Therapeutics|
|GeneCentric Therapeutics||Miach Orthopaedics, Inc.||Townsquare Media, Inc.|
|Amunix Pharmaceuticals Inc.||Roland DGA||The Alliance for a Healthier Generation|
|TARIS Bio™||KidKraft, Inc.||Atara Biotherapeutics, Inc.|
|StrideBio, Inc||United Cerebral of Los Angeles, Ventura and Santa Barbara Counties||Clinical Genomics|
|Tragara Pharmaceuticals Inc.||UroGen Pharma Ltd.||Riverview Financial Corporation|
|WSFS Financial Corporation||Natera, Inc.||OrderMyGear|
|Obalon Therapeutics||Hensel Phelps||Apollo Robotics|
|LSB Industries, Inc.|
Would you like to receive our weekly CEO Moves directly in your email? Click the SIGN ME UP! button on the right of the blog page.
Should you have any CEO Moves to report, please email us. CEO Moves is published by Samuel Dergel (Executive Search Consultant with Dergel Executive Search). Samuel can be reached by email at firstname.lastname@example.org or by phone at +1 (415) 738-2070.
+ + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + + +
Angion Biomedica Corp. [UNIONDALE, NY] announced the appointments of Jay R. Venkatesan as President and Chief Executive Officer. Venkatesan is also a Managing Partner at Alpine BioVentures. Prior to Angion, Venkatesan served as President of Alpine Immune Sciences, which he co-founded as a Managing Partner of Alpine BioVentures, and where he remains on its Board of Directors.
Allena Pharmaceuticals, Inc. [NEWTON, MA] (NASDAQ:ALNA) announced that Louis Brenner President and Chief Operating Officer at Allena, will be promoted to Chief Executive Officer and appointed to the Board of Directors effective February 1, 2019. Brenner will succeed Alexey Margolin as Chief Executive Officer. Margolin, who co-founded Allena in 2011, will transition to Chairman of the Board effective February 1, 2019. Brenner has served as Chief Operating Officer of Allena since April 2015 and as President since February 2017. Prior to joining Allena, Brenner served as Chief Medical Officer at Idera Pharmaceuticals, Chief Medical Officer at Radius Health, and Senior Vice President at AMAG Pharmaceuticals.
Owens Corning [TOLEDO, OH] (NYSE: OC) announced that it has selected Brian D. Chambers current President and Chief Operating Officer to succeed Mike Thaman as Chief Executive Officer effective April 18, 2019. Thaman, who has served as Chairman since 2002 and as CEO since 2007, announced his retirement as CEO and will remain with the company in the role of Executive Chairman. Chambers, who was promoted to President and COO in August 2018, will retain the title of President as he assumes the CEO role. Previously, Chambers served as President of the Roofing business since 2014.
Retrophin, Inc. [SAN DIEGO] (NASDAQ: RTRX) announced the appointment of Eric Dube, as president and chief executive officer. Dube joins Retrophin from ViiV Healthcare, where he served as president of North America. Dube will also serve as a member of Retrophin’s Board of Directors. Dube most recently led the North America business at ViiV Healthcare. Prior to ViiV, Dube worked at GlaxoSmithKline plc for more than 18 years, in roles including leading the U.S. Oncology and Global Respiratory businesses.
RetailMeNot, Inc. [AUSTIN, TX] announced that Marissa Tarleton has been appointed chief executive officer. Tarleton has served as chief marketing officer of RetailMeNot since 2015. Cotter Cunningham, founder and chief executive officer, will move into a chairman role. Tarleton joined RetailMeNot in 2015 as the chief marketing officer. Prior to RetailMeNot, Tarleton served in multiple regional and global marketing and e-commerce leadership roles at Dell. Prior to Dell, Tarleton worked in advertising in New York City for both Ogilvy & Mather and Foote Cone & Belding.
Aver Healthcare [COLUMBUS, OH]announced that Bill Nordmark, currently EVP & Chief Commercial Officer of Aver, assumed the role of President & Chief Executive Officer, succeeding Nick Augustinos, who becomes Aver’s Chairman of the Board after serving for three years as its President & Chief Executive Officer. Nordmark has served as Aver’s EVP & Chief Commercial Officer since May of 2017.
Tizona Therapeutics, Inc. [SOUTH SAN FRANCISCO, CA] announced that Scott Clarke has joined the company as its chief executive officer. Clarke joins from Roche where he served as the Global Head of Oncology Partnering and Head of Asia and Emerging Markets Partnering. Prior to Roche, Clarke held positions of increasing responsibility at BioMarin Pharmaceutical, Inc, where he most recently served as Senior Vice President of Product Development.
GeneCentric Therapeutics [DURHAM, NC] announced the appointment of Michael V. Milburn as Chief Executive Officer and President. Milburn will also join GeneCentric’s Board of Directors. Myla Lai-Goldman, founder, current CEO and President, will assume the newly created role of Executive Chairperson of the Board of Directors. Milburn joined GeneCentric in September of 2018 as Chief Scientific Officer. Previously, Milburn was CSO at Metabolon and prior to Metabolon, he served as Senior Vice President of Research and Corporate Development at Sirtris Pharmaceuticals and Senior Vice President of Research at Plexxikon.
Miach Orthopaedics, Inc. [WESTBOROUGH, MA] announced that Martha Shadan has been appointed president and chief executive officer. During most of 2018, Shadan served as global vice president of marketing at Smith & Nephew plc, a role she assumed after the company acquired Rotation Medical, where she was president and CEO.
Townsquare Media, Inc. [GREENWICH, CO] (NYSE: TSQ) announced the departure of its Co-Founder and Co-Chief Executive Officer, Dhruv Prasad, who has resigned from his positions as Co-Chief Executive Officer and Director of the Company, effective January 31, 2019. Bill Wilson will transition from Co-Chief Executive Officer to serve as the sole Chief Executive Officer of the Company. Wilson joined Townsquare in September 2010 and was appointed Co-Chief Executive Officer in October 2017. Prior to his appointment, Wilson served as Executive Vice President and Chief Content & Digital Officer of the Company. Previously, Wilson was President of AOL Media from 2006 to May 2010.
Amunix Pharmaceuticals Inc. [MOUNTAIN VIEW, CA] announced the appointment of Angie You as Chief Executive Officer. Prior to joining Amunix, Dr. You served as Chief Business & Strategy Officer and Head of Commercial at Sierra Oncology. Prior to Sierra, Dr. You served as Chief Business Officer of Aragon Pharmaceuticals. Dr. You also served as Chief Business Officer at Synosia Therapeutics and Ren Pharmaceuticals.
The Alliance for a Healthier Generation [NEW YORK] has named Kathy Higgins to serve as the chief executive officer. Higgins succeeds Howell Wechsler, who retired in October 2018. Higgins joins Healthier Generation following more than 30 years at Blue Cross and Blue Shield of North Carolina where her roles span leading public health engagement, corporate communications, community relations, and corporate affairs.
TARIS Bio™ [LEXINGTON, MA] announced that Tony Kingsley has joined the company as president and chief executive officer and was elected to the TARIS board of directors. Purnanand Sarma, has stepped down to pursue new opportunities and will advise the company during a brief transition period. Prior to joining TARIS, Kingsley served as president and chief operating officer at The Medicines Company. Previously, Kingsley was global commercial head at Biogen.
KidKraft, Inc. [DALLAS] announced Geoff Walker has been appointed president and chief executive officer and will serve as a member of the company’s board of directors. Walker was most recently executive vice president and chief strategic technology officer for Mattel. Previously Walker was the executive vice president and general manager for the North American commercial division, executive vice president of the Fisher-Price global brands team, and general manager and senior vice president of Europe, Eastern Europe and Russia.
Atara Biotherapeutics, Inc. [SOUTH SAN FRANCISCO, CA] (Nasdaq: ATRA) announced that Isaac Ciechanover plans to step down as the Company’s President and Chief Executive Officer. The Board of Directors has initiated a search for his successor. Ciechanover will remain in his role as President and CEO until the earlier of the appointment of his successor or June 30, 2019.
StrideBio, Inc. [DURHAM, NC] announced that it has appointed Sapan Shah as Chief Executive Officer and a member of the company’s board. Shah has previously served as CEO at ARMGO Pharma, Ezose Sciences, and Shionogi Inc.
United Cerebral Palsy of Los Angeles, Ventura and Santa Barbara Counties [WOODLAND HILLS, CA] announce the appointment of Lori Anderson as the organization’s President and Chief Executive Officer, effective January 21, 2019. The current President and CEO, Ronald S. Cohen, will be retiring after leading the organization for over 30 years. Prior to joining the UCPLA team, Anderson was the Chief Operating Officer and Vice President of Residential Services for Bethesda Lutheran Communities. Previously, Anderson served as Bethesda’s Regional Director of California. Before joining Bethesda Lutheran Communities in 2013, Anderson served as the Vice President of Mission Services for Goodwill in Springfield, Illinois.
Clinical Genomics [BRIDGEWATER, NJ] announced the appointment of Betsy Hanna as president and chief executive officer. Hanna will also join the Clinical Genomics Board of Directors. Hanna succeeds Lawrence LaPointe as CEO, who will transition to the new role of chief innovation officer. Most recently Hannah was Clinical Genomics’ chief commercial officer. Hanna joined Clinical Genomics from Origin, Inc. where she was the president and chief operating officer.
Adastra Pharmaceuticals Inc. [PRINCETON, NJ] announced the appointment of Scott Megaffin as Chief Executive Officer and a member of the Board of Directors. Megaffin replaces Tom Estok, who will remain active with the company as an advisor and continue in his role on the Board of Directors. Prior to joining the company, Megaffin was President of Churchill Pharmaceuticals LLC.
UroGen Pharma Ltd. [NEW YORK] (Nasdaq:URGN) announced the appointment of Elizabeth (Liz) Barrett as President and Chief Executive Officer. Barrett will also serve on the Company’s Board of Directors. Barrett replaces Ron Bentsur. Barrett was CEO of Novartis Oncology and a member of the Executive Committee of Novartis, and has previously served as Global President of Oncology at Pfizer Inc. Prior to Pfizer, Barrett was Vice President and General Manager of the Oncology Business Unit at Cephalon Inc.
Riverview Financial Corporation [HARRISBURG, PA] (NASDAQ: RIVE) the holding company of Riverview Bank, announced that Kirk D. Fox has resigned as Chief Executive Officer and Director of Riverview Financial and Riverview Bank. Riverview Financial and Riverview Bank President, Brett D. Fulk, has been named President and Chief Executive Officer of Riverview Financial and Riverview Bank. Fulk is currently a member of the Board of Directors of both entities. Fulk has been the President and a director of Riverview Financial and Riverview Bank since 2015. Fulk joined Riverview Bank as the Chief Operations Officer in 2011. From 1991 until 2011, Fulk served as a Managing Director of Commercial Services, Pennsylvania division, Regional Executive, and Region President for Susquehanna Bank and its predecessor bank, Community Banks.
WSFS Financial Corporation [WILMINGTON, DE] (Nasdaq: WSFS) has named Rodger Levenson is the new President and Chief Executive and a member of its Board of Directors. Levenson is a long-time banker in the Greater Delaware Valley and has been a member of WSFS’ executive leadership team since 2006, most recently serving as Executive Vice President and Chief Operating Officer.
Natera, Inc. [SAN CARLOS, CA] (NASDAQ: NTRA) has announced the appointment of Steve Chapman as Chief Executive Officer. Previously, Chapman was the company’s COO and will succeed Matthew Rabinowitz, Co-founder and CEO. Rabinowitz will remain as Executive Chairman. Since joining Natera in 2010, Chapman has served in roles ranging from Vice President of Sales, to Senior Vice President of Commercial, to Chief Commercial Officer and most recently COO.
Obalon Therapeutics, Inc. [SAN DIEGO] (NASDAQ:OBLN) announced the promotion of Kelly Huang to Chief Executive Officer. Huang has served as Obalon’s Chief Operating Officer since September 2017 and was promoted to President in August 2018. Andy Rasdal, who has served as CEO since Obalon’s founding in 2008 will serve as Executive Chairman.
Hensel Phelps [GREELEY, CO] announced the retirement of Chief Executive Officer Jeff Wenaas and the appointment of Michael (Mike) J. Choutka as President and Chief Executive Officer. Choutka most recently served as President and Chief Operating Officer (COO) for Hensel Phelps. Choutka began his career with Hensel Phelps, rising through the ranks from Field Engineer, Office Engineer, Project Engineer, Project Manager, Operations Manager, District Manager / Vice President, and Executive Vice President before being appointed President and Chief Operating Officer.
LSB Industries, Inc. [OKLAHOMA CITY] (NYSE:LXU) announced that Dan Greenwell elected not to enter into a new employment agreement and has stepped down from his role as Chairman and Chief Executive Officer. The Board of Directors has appointed Mark Behrman, LSB’s current Executive Vice President and Chief Financial Officer, to serve as the Company’s new President and Chief Executive Officer and join its Board of Directors. Behrman has been LSB’s Executive Vice President and Chief Financial Officer since June 2015. Behrman joined LSB in April 2014 as Senior Vice President, Corporate Development.